ARENA PHARMACEUTICALS INC's ticker is ARNAXXXX and the CUSIP is 040047102. A total of 120 filers reported holding ARENA PHARMACEUTICALS INC in Q3 2014. The put-call ratio across all filers is 2.04 and the average weighting 0.0%.
Quarter-by-quarter ownership
| Value | Shares | Weighting | ||||
|---|---|---|---|---|---|---|
| Q1 2017 | $86,000 | -22.5% | 59,138 | -23.9% | 0.00% | – |
| Q4 2016 | $111,000 | +20.7% | 77,752 | +47.5% | 0.00% | – |
| Q3 2016 | $92,000 | +1.1% | 52,708 | 0.0% | 0.00% | – |
| Q2 2016 | $91,000 | -12.5% | 52,708 | 0.0% | 0.00% | – |
| Q1 2016 | $104,000 | +3.0% | 52,708 | -0.1% | 0.00% | – |
| Q4 2015 | $101,000 | -2.9% | 52,787 | 0.0% | 0.00% | – |
| Q3 2015 | $104,000 | -55.9% | 52,787 | 0.0% | 0.00% | – |
| Q2 2015 | $236,000 | +24.2% | 52,787 | +25.1% | 0.00% | – |
| Q1 2015 | $190,000 | +68.1% | 42,195 | +30.4% | 0.00% | – |
| Q4 2014 | $113,000 | -16.3% | 32,356 | 0.0% | 0.00% | – |
| Q3 2014 | $135,000 | – | 32,356 | – | 0.00% | – |
Download | ||||||
Other shareholders
| Name | Shares | Value | Weighting ↓ |
|---|---|---|---|
| Camber Capital Management LP | 9,750,000 | $18,623,000 | 1.60% |
| DAFNA Capital Management LLC | 381,600 | $729,000 | 0.72% |
| SENZAR ASSET MANAGEMENT, LLC | 1,766,991 | $3,374,953,000 | 0.49% |
| DEERFIELD MANAGEMENT COMPANY, L.P. (SERIES C) | 4,640,877 | $8,864,000 | 0.34% |
| Lyons Wealth Management, LLC. | 56,665 | $110,000 | 0.14% |
| FEDERATED HERMES, INC. | 5,648,920 | $10,789,000 | 0.04% |
| WELLINGTON MANAGEMENT GROUP LLP | 33,909,459 | $64,767,000 | 0.02% |
| Cubist Systematic Strategies, LLC | 185,166 | $354,000 | 0.02% |
| GAM Holding AG | 523,164 | $997,000 | 0.02% |
| STEVENS CAPITAL MANAGEMENT LP | 191,236 | $365,000 | 0.02% |